Search

You searched for "polynucleotides"

25 results found

Polynucleotides: A scientific explanation

4 December 2024 | | PMFA - Aesthetic Medicine
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Introduction and background This article offers an objective analysis of a new...

Addressing forgotten areas: Combining HA’s and polynucleotides for ageing hands

3 October 2024 | | PMFA - Aesthetic Medicine, PMFA - Hand & Wrist Surgery
When it comes to treating our patients, the most forgotten areas I see are the neck and hands. The hands are prone to premature ageing as they are exposed to many factors and suffer from volume loss, age spots, dry...

Skin dyspigmentation induced by triamcinolone injection treated with Nd:YAG picosecond laser in combination with polynucleotides

3 October 2024 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Non-surgical rhinoplasty is a popular cosmetic procedure that involves the use of injectable fillers to improve the shape of the nose without surgery. There are many different materials available on the market such as hyaluronic acid, collagen stimulators, etc. Silicone...

Croma-Pharma UK Training: Polynucleotides (21 Sep)

21 September 2025

Croma-Pharma UK Training: Polynucleotides (6 Oct)

6 October 2025

Croma-Pharma UK Training: Polynucleotides (12 Oct)

12 October 2025

Croma-Pharma UK Training: Polynucleotides (17 Oct)

17 October 2025

Croma-Pharma UK Training: Polynucleotides (7 Nov)

7 November 2025

Croma-Pharma UK Training: Polynucleotides (16 Nov)

16 November 2025

PhilArt is now PolyPhil™: NEW NAME, SAME TRUSTED QUALITY

12 March 2025 | Research & Development
CROMA-PHARMA®, a global leader in minimally-invasive aesthetic medicine, is excited to announce that its range of injectable polynucleotides “PhilArt” is rebranding to better reflect the products’ exceptional attributes and to position them for global market expansion. PolyPhil™ succeeds the well-established...

DermaFocus introduces the First Polynucleotide and Hyaluronic Acid Combination Product to the UK

22 March 2023 | Research & Development, Contracts & Distributors
The UK’s leading polynucleotide distributor DermaFocus has added an innovative new product to its portfolio to complement its existing regenerative range.

PhilArt next for 35-year-old knee scar

3 June 2024 | | PMFA - Aesthetic Medicine
In our dynamic field, staying ahead means embracing innovation, and understanding the evolving preferences of both practitioners and patients; recognising the trends that shape our industry. The biostimulator injections’ market has rapidly risen to prominence, ranking among the top three...
  • 1 (current)
  • 2
  • 3